Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children
- PMID: 10383558
- PMCID: PMC2014881
- DOI: 10.1046/j.1365-2125.1999.00948.x
Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children
Abstract
Aims: To measure morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children following a single intravenous dose of morphine.
Methods: Twenty-nine paired samples of cerebrospinal fluid and plasma were collected from children with leukaemia undergoing therapeutic lumbar puncture. An intravenous dose of morphine was administered at selected intervals before the procedure. Concentrations of morphine and morphine-6-glucuronide (M6G) were measured in each sample. Morphine was measured using a specific radioimmunoassay (r.i.a.) and M6G was measured using a novel enzyme-linked immunosorbent assay (ELISA).
Results: The ELISA for measuring M6G was highly sensitive. The intra-and interassay variations were less than 15%. Using a two-compartment model for plasma morphine, the area under the curve to infinity (AUC, 7143 ng ml-1 min), volume of distribution (3.6 l kg-1 ) and elimination half-life (88 min) were comparable with those reported in adults. Clearance (35 ml min-1 ) was higher than that in adults. Morphine-6-glucuronide was readily synthesized by the children in this study. The elimination half-life (321 min) and AUC (35507 ng ml-1 min) of plasma M6G were much greater than those of morphine.
Conclusions: Extensive metabolism of morphine to M6G in children with cancer has been demonstrated. These data provide further evidence to support the importance of M6G accumulation after multiple doses. There was no evidence that morphine passed more easily into the CSF of children than adults.
Figures


Similar articles
-
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.Br J Clin Pharmacol. 2002 Dec;54(6):592-603. doi: 10.1046/j.1365-2125.2002.t01-1-01689.x. Br J Clin Pharmacol. 2002. PMID: 12492606
-
Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.Br J Clin Pharmacol. 1996 Jun;41(6):531-7. doi: 10.1046/j.1365-2125.1996.03539.x. Br J Clin Pharmacol. 1996. PMID: 8799518 Free PMC article. Clinical Trial.
-
Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration.Pain. 1990 Apr;41(1):15-18. doi: 10.1016/0304-3959(90)91103-P. Pain. 1990. PMID: 2352761
-
Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.Br J Anaesth. 2014 Dec;113(6):935-44. doi: 10.1093/bja/aeu186. Epub 2014 Jul 1. Br J Anaesth. 2014. PMID: 24985077 Review.
-
Systematic review of factors affecting the ratios of morphine and its major metabolites.Pain. 1998 Jan;74(1):43-53. doi: 10.1016/S0304-3959(97)00142-5. Pain. 1998. PMID: 9514559
Cited by
-
Strong opioids in pediatric palliative medicine.Paediatr Drugs. 2005;7(1):1-9. doi: 10.2165/00148581-200507010-00001. Paediatr Drugs. 2005. PMID: 15777107 Review.
-
Drug trials in children: problems and the way forward.Br J Clin Pharmacol. 2000 Feb;49(2):93-7. doi: 10.1046/j.1365-2125.2000.00125.x. Br J Clin Pharmacol. 2000. PMID: 10671901 Free PMC article. Review. No abstract available.
-
Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder.Subst Abuse Rehabil. 2024 Apr 3;15:43-57. doi: 10.2147/SAR.S431270. eCollection 2024. Subst Abuse Rehabil. 2024. PMID: 38585160 Free PMC article. Review.
-
Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis.PLoS Comput Biol. 2019 Jun 13;15(6):e1007117. doi: 10.1371/journal.pcbi.1007117. eCollection 2019 Jun. PLoS Comput Biol. 2019. PMID: 31194730 Free PMC article.
-
Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery.Eur J Clin Pharmacol. 2007 Sep;63(9):837-42. doi: 10.1007/s00228-007-0329-x. Epub 2007 Jul 10. Eur J Clin Pharmacol. 2007. PMID: 17619868 Clinical Trial.
References
-
- Shimomura K, Kamata O, Ueki S, Ida S, Oguri K. Analgesic effect of morphine glucuronides. Tohoku J Exp Med. 1971;105:45–52. - PubMed
-
- Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 1987;41:2845–2849. - PubMed
-
- Abbott FV, Palmour RM. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 1988;43:1685–1695. - PubMed
-
- Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6-beta glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989;251:477–483. - PubMed
-
- Gong QL, Hedner T, Hedner J, Bjorkman R, Nordberg G. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol. 1991;193:47–56. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous